Home › Calculator › MCRB Dividend Calculator 2026
MCRB Dividend DRIP Calculator 2026
32.73% YieldHealthcareSeres Therapeutics, Inc. · NASDAQ
Price: $6.11 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When MCRB pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your MCRB snowball 📈
$10,000 in MCRB → $43736879.73M in 10 years · $3,633,898,609,718.91/month
About Seres Therapeutics, Inc. (MCRB) — Dividend Analysis 2026
Seres Therapeutics, Inc. is a pioneering microbiome therapeutics firm dedicated to engineering bacterial consortia that modulate host cells and tissues to combat various diseases. Their flagship therapeutic, SER-109, an oral microbiome treatment, has successfully concluded Phase III clinical trials for the management of Clostridioides difficile infection (CDI). The company's pipeline further encompasses SER-155, a synthetically cultured bacterial formulation currently undergoing Phase Ib evaluation. This candidate aims to mitigate the risk of gastrointestinal and bloodstream infections, alongside graft-versus-host disease, in vulnerable patients undergoing allogeneic hematopoietic stem cell or solid organ transplantation. Additionally, Seres Therapeutics is advancing SER-287 and SER-301, both in Phase Ib for ulcerative colitis, as well as SER-401, which targets metastatic melanoma, and SER-262, also directed at Clostridioides difficile infection. Seres maintains strategic alliances through licensing and collaboration agreements with entities such as Nestec Ltd. and Memorial Sloan Kettering Cancer Center. Established in 2010, the company previously operated as Seres Health, Inc. before adopting its current name in May 2015, and it maintains its principal offices in Cambridge, Massachusetts.
Compare MCRB with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full MCRB DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open MCRB position with:
🌍 MCRB Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold MCRB.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 32.73% | 29.93% | $3,273 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 27.82% | 25.02% | $2,782 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 26.18% | 23.38% | $2,618 / yr |
| 🇬🇧 UK ISA | 0% | 32.73% | 29.93% | $3,273 / yr |
| 🇬🇧 UK Taxable | 8.75% | 29.87% | 27.07% | $2,987 / yr |
| 🇨🇦 TFSA | 0% | 32.73% | 29.93% | $3,273 / yr |
| 🇨🇦 CA Taxable | 25% | 24.55% | 21.75% | $2,455 / yr |
| 🇦🇺 Super (pension) | 15% | 27.82% | 25.02% | $2,782 / yr |
| 🇦🇺 AU Taxable | 30% | 22.91% | 20.11% | $2,291 / yr |
| 🇩🇪 DE Taxable | 26.375% | 24.10% | 21.30% | $2,410 / yr |
| 🇫🇷 FR Taxable | 30% | 22.91% | 20.11% | $2,291 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 MCRB Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 MCRB Dividend Payment Schedule
MCRB pays quarterly — 4 times per year. Next ex-div: TBD.
📊 MCRB vs Healthcare Benchmarks
How MCRB compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MCRB sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ MCRB Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-07-08 | 6,500 | $7.14 | $46.4K | ||
| A-Award | 2026-07-08 | 50,000 | $9.13 | $456.5K | ||
| A-Award | 2026-07-08 | 25,000 | $9.13 | $228.3K | ||
| A-Award | 2026-07-08 | 7,500 | $9.13 | $68.5K | ||
| A-Award | 2026-07-08 | 6,500 | $7.14 | $46.4K | ||
| A-Award | 2026-07-08 | 6,500 | $7.14 | $46.4K | ||
| A-Award | 2026-07-08 | 6,500 | $7.14 | $46.4K | ||
| A-Award | 2026-07-08 | 6,500 | $7.14 | $46.4K | ||
| A-Award | 2026-07-08 | 6,500 | $7.14 | $46.4K | ||
| A-Award | 2026-07-08 | 6,500 | $7.14 | $46.4K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MCRB dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Seres Therapeutics, Inc. (MCRB) is currently trading at $6.11, trading near its 52-week low. The current dividend yield is 32.73% based on an annual payout of $2.00 per share.
MCRB (Seres Therapeutics, Inc.) — 32.73% Dividend Yield Analysis
Seres Therapeutics, Inc. (MCRB) is a healthcare stock currently trading at $6.11 with a dividend yield of 32.73%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (32.73%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.